BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 448140)

  • 1. Role of lipid fatty acyl composition and membrane fluidity in the resistance of Acholeplasma laidlawii to complement-mediated killing.
    Dahl JS; Dahl CE; Levine RP
    J Immunol; 1979 Jul; 123(1):104-8. PubMed ID: 448140
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysis of Acholeplasma laidlawii by antibodies and complement.
    Brunner H; Dörner I; Schiefer HG; Krauss H; Wellensiek HJ
    Infect Immun; 1976 Jun; 13(6):1671-7. PubMed ID: 971945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of independent variations in fatty acid structure and chain length on lipid polar headgroup composition in Acholeplasma laidlawii B membranes: regulation of lamellar/nonlamellar phase propensity.
    Yue AW; Wong BC; Rieder J; Lewis RN; Mannock DA; McElhaney RN
    Biochemistry; 2003 Feb; 42(5):1309-17. PubMed ID: 12564934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of membrane-lipid phase transitions on membrane structure and on the growth of Acholeplasma laidlawii B.
    McElhaney RN
    J Supramol Struct; 1974; 2(5-6):617-28. PubMed ID: 4461849
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement-mediated killing of Acholeplasma laidlawii by antibodies to various membrane components.
    Dörner I; Brunner H; Schiefer HG; Wellensiek HJ
    Infect Immun; 1976 Jun; 13(6):1663-70. PubMed ID: 61175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum.
    Dörner I; Brunner H; Schiefer HG; Loos M; Wellensiek HJ
    Infect Immun; 1977 Oct; 18(1):1-7. PubMed ID: 908614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for fatty acid composition of complex cellular lipids in the susceptibility of tumor cells to humoral immune killing.
    Schlager SI; Ohanian SH
    J Immunol; 1979 Jul; 123(1):146-52. PubMed ID: 448144
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies specific for human albumin function as blocking antibodies when attached to erythrocyte-bound albumin.
    Houle JJ; Hoffmann EM
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1161-6. PubMed ID: 8352772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on Acholeplasma laidlawii grown on branched-chain fatty acids.
    Bouvier P; Op Den Kamp JA; Van Deenen LL
    Arch Biochem Biophys; 1981 Apr; 208(1):242-7. PubMed ID: 7259182
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical analysis of lipid-modified membrane proteins in Acholeplasma laidlawii.
    Le Hénaff M; Chollet A; Fontenelle C
    Curr Microbiol; 2001 Dec; 43(6):424-8. PubMed ID: 11685510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
    Nemerow GR; Yamamoto KI; Lint TF
    J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of acyl chain composition on production of mycoplasmavirus MV-L2 by Acholeplasma laidlawii.
    Steinick LE; Wieslander A
    Isr J Med Sci; 1984 Sep; 20(9):788-92. PubMed ID: 6511354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 19F-nuclear magnetic resonance study of glycerolipid fatty acyl chain order in Acholeplasma laidlawii B membranes.
    McDonough B; Macdonald PM; Sykes BD; McElhaney RN
    Yale J Biol Med; 1983; 56(5-6):391-6. PubMed ID: 6679141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous species restriction of the complement-mediated killing of nucleated cells.
    Yamamoto H; Blaas P; Nicholson-Weller A; Hänsch GM
    Immunology; 1990 Aug; 70(4):422-6. PubMed ID: 1697561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of Acholeplasma laidlawii membrane acyl proteins in Escherichia coli.
    Tegman V; Wallbrandt P; Nyström S; Johansson KE; Jonsson BH; Wieslander A
    Isr J Med Sci; 1987 May; 23(5):408-13. PubMed ID: 3312093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accumulation of cholesterol in Acholeplasma laidlawii membranes in the steady-state phase of culture growth].
    Kapitanov AB; Ladygina VG; Mukhankin AI; Ivanova VF; Klebanov GI
    Biokhimiia; 1983 Nov; 48(11):1921-6. PubMed ID: 6661465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of various culturing conditions of Acholeplasma laidlawii on the yield and properties of the cells and cell membrane.
    Dresdner G
    Acta Microbiol Pol; 1977; 26(1):45-57. PubMed ID: 67754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-induced modifications in membrane fluidity: studies with resealed and glutaraldehyde-treated erythrocyte membrane ghosts.
    Giavedoni EB; Mason RP; Dalmasso AP
    J Immunol; 1978 Jun; 120(6):2003-7. PubMed ID: 207778
    [No Abstract]   [Full Text] [Related]  

  • 19. A mycoplasma mutant resistant to lysis by C: variations in membrane composition and altered response to the terminal C complex.
    Dahl JS; Hellewell SB; Levine RP
    J Immunol; 1977 Oct; 119(4):1419-26. PubMed ID: 894046
    [No Abstract]   [Full Text] [Related]  

  • 20. The molecular structure of the membrane of Acholeplasma laidlawii.
    Engelman DM
    Chem Phys Lipids; 1972 May; 8(4):298-302. PubMed ID: 5041943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.